Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Edwards To Pay Up To $690m For Cardioband-Maker Valtech

Executive Summary

The Cardioband system is a transcatheter annuloplasty device for repair of mitral and tricuspid valves that should be a natural fit with Edwards transcatheter mitral valve development program. Israel-based Valtech had a deal in September 2015 to be acquired by HeartWare for $900m, but that deal fell through after HeartWare investors protested.


Related Content

M&A Analysis: November Deal Making Hits Whole New Low
Edwards, Boston Sci Make TAVR Progress In Europe
Medtronic Ups Its Heart-Failure Competitive Strength With HeartWare Buy
Shareholders Compel HeartWare To Drop Valtech Deal, Stay Focused On VADS
Transcatheter Mitral Valve Therapy: Opportunities And Challenges


Related Companies